New Delhi, Dec 7 (IANS) The development of an indigenous antibiotic Nafithromycin is an important achievement by Indian scientists, and may be crucial in the country’s fight against antimicrobial resistance (AMR), said experts on Saturday. Developed by Indian pharma company Wockhardt, with support from the Biotechnology Industry Research Assistance Council (BIRAC), Nafithromycin targets Community-Acquired Bacterial Pneumonia (CABP). The drug marketed as “Miqnaf” is effective against CABP caused by drug-resistant bacteria, which disproportionately affects vulnerable populations such as children, the elderly, and those with compromised immune systems. “Development of the indigenous antibiotic
Hence then, the article about antibiotic nafithromycin key achievement by indian scientists to fight amr experts was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Antibiotic Nafithromycin key achievement by Indian scientists to fight AMR: Experts )